| Code | 9494D | ||||||||||
| MA number | 20/0017/22-S | ||||||||||
| Product Form: | sol inj 10x2 ml/10 mg (amp.skl.) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | hameln pharma gmbh, Germany | ||||||||||
| Therapeutic Class: | 20 - ANTIEMETICA, ANTIVERTIGINOSA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | glass ampoule | ||||||||||
| Route of admin.: | Intramuscular or intravenous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 13.02.2022 |
| Validity: | 13.02.2027 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric contraindication: | Yes |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Metoclopramide hameln 5 mgml sol inj_01 2022.pdf
|
| SPC: |
SPC_Metoclopramide hameln 5 mgml sol inj_01 2022.pdf
|
| Safety feature | Yes |
| Data update: | 17.02.2022 |
